Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

Psychedelics developer Definium scores more positive data for LSD pill

Results from a late-stage study focused on generalized anxiety disorder were a “clean win” to analysts, who believe Definium has a drug with multibillion-dollar sales potential.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

Next 10 U.S. Biopharma Clusters

Next 10 U.S. Biopharma Clusters

For the first time, GEN 's Alex Philippidis examines the top regions and top states just below the 10 largest regions for life sciences activity, as the field looks beyond the East and West Coasts for…

More from Wednesday 12 August →